Literature DB >> 31986342

Global patterns and trends in cancers of the lip, tongue and mouth.

Adalberto Miranda-Filho1, Freddie Bray2.   

Abstract

OBJECTIVES: Global descriptions of international patterns and trends in oral cancer are informative in providing insight into the shifting epidemiologic patterns and the potential prevention of these tumours. We present global statistics on these cancers using the comprehensive set of national estimates and recorded data collated at the International Agency for Research on Cancer (IARC).
METHODS: The estimated number of lip and oral cavity cases and deaths in the 185 countries for the year 2018 was extracted from IARC's GLOBOCAN database of national estimates. To examine trends, recorded data series on lip and oral cavity cancers, as well as corresponding population-at-risk data were extracted from successive volumes of Cancer Incidence in Five Continents.
RESULTS: Globally, the highest incidence was found in South-Central Asia and parts of Oceania, with the highest estimated incidence rates in Papua New Guinea, Pakistan and India. The highest observed rates of lip cancer were in Australia, while India had the highest incidence rates of mouth and oral tongue cancer. Trends are diverse, with lip cancer incidence rates continuing to decrease for both sexes; the incidence rates of mouth cancer are also in decline in males, although increasing rates among females were observed in some populations.
CONCLUSION: There are some grounds for optimism given the prospects for control of these cancers. Primary prevention should however focus on the reduction of the main causes, namely, tobacco and alcohol consumption.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Incidence; Lip cancer; Mortality; Mouth cancer; Tongue cancer

Mesh:

Year:  2020        PMID: 31986342     DOI: 10.1016/j.oraloncology.2019.104551

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  46 in total

1.  Molecular alterations in oral cancer using high-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue.

Authors:  Varshasnata Mohanty; Yashwanth Subbannayya; Shankargouda Patil; Vinuth N Puttamallesh; Mohd Altaf Najar; Keshava K Datta; Sneha M Pinto; Sameera Begum; Neeta Mohanty; Samapika Routray; Riaz Abdulla; Jay Gopal Ray; David Sidransky; Harsha Gowda; T S Keshava Prasad; Aditi Chatterjee
Journal:  J Cell Commun Signal       Date:  2021-03-08       Impact factor: 5.782

Review 2.  Cell-in-Cell Events in Oral Squamous Cell Carcinoma.

Authors:  Leonardo de Oliveira Siquara da Rocha; Bruno Solano de Freitas Souza; Daniel W Lambert; Clarissa de Araújo Gurgel Rocha
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

3.  Identification of oral squamous cell carcinoma markers MUC2 and SPRR1B downstream of TANGO.

Authors:  Tomonori Sasahira; Miyako Kurihara-Shimomura; Hiroyuki Shimomura; Anja Katrin Bosserhoff; Tadaaki Kirita
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-23       Impact factor: 4.553

4.  Oesophageal carcinoma with solitary patellar metastasis: a rare case report.

Authors:  Yi Zhao; Qianqian Zhang; Helin Feng; Xiyan Zhu
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

Review 5.  [Global oral health in the international health policy spotlight-challenges and new opportunities for sustainable improvement].

Authors:  Habib Benzian; Stefan Listl
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-06-08       Impact factor: 1.513

Review 6.  Lessons learned from the INHANCE consortium: An overview of recent results on head and neck cancer.

Authors:  Francesca Bravi; Yuan-Chin Amy Lee; Mia Hashibe; Paolo Boffetta; David I Conway; Monica Ferraroni; Carlo La Vecchia; Valeria Edefonti
Journal:  Oral Dis       Date:  2020-07-16       Impact factor: 3.511

7.  Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation.

Authors:  Julia Rosemann; Lisa Müller; Jonas Weiße; Matthias Kappler; Alexander W Eckert; Markus Glaß; Danny Misiak; Stefan Hüttelmaier; Wolfgang G Ballhausen; Mechthild Hatzfeld; Monika Haemmerle; Tony Gutschner
Journal:  Mol Cancer       Date:  2021-06-11       Impact factor: 27.401

8.  A non-toxic, reversibly released imaging probe for oral cancer that is derived from natural compounds.

Authors:  Magda Ghanim; Nicola Relitti; Gavin McManus; Stefania Butini; Andrea Cappelli; Giuseppe Campiani; K H Mok; Vincent P Kelly
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

9.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.

Authors:  Tanya Walsh; Richard Macey; Alexander R Kerr; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya
Journal:  Cochrane Database Syst Rev       Date:  2021-07-20

10.  Combinatorial treatment with Gefitinib and Bay11-7085 sensitizes primary Gefitinib-resistant OSCC cells by influencing the EGFR- NFκB signaling axis.

Authors:  M S Sinto; Shaji Thomas; S Kannan
Journal:  Med Oncol       Date:  2021-08-06       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.